Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The data that support the findings of this study are available from the corresponding author, [KAD], upon reasonable request.
Fields of Study & Subjects
Hemophilia Treatment and Research
Platelet Disorders and Treatments
Coagulation
Bradykinin
Polyphosphates
and Angioedema
Publication details
- Journal / source
- Haemophilia
- Volume
- 32
- Issue
- 4
- Pages
- 1090–1092
- Publication date
- 27 March 2026
- Language
- EN